We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Merck and Co Inc | NYSE:MRK | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 128.80 | 44 | 09:29:46 |
(FROM THE WALL STREET JOURNAL 5/18/15) By Stephen Grocer
Companies are turning to the capital markets at a record pace to fund acquisitions.
So far this year, buyers have raised $159 billion in debt and $47.3 billion in equity to fund purchases, according to Dealogic. Both are highs for the first 4 1/2 months of the year and easily exceed previous records: $112 billion of debt in 2009 and $35 billion of equity in 2007.
Health-care deal making has driven much of the surge in M&A financing. So far this year, Actavis PLC sold $21 billion of corporate bonds to fund its purchase of Allergan Inc.; AbbVie Inc. raised $16.7 billion through a bond sale to support its pending acquisition of Pharmacyclics Inc.; and Merck & Co. sold $8 billion of bonds for its purchase of Cubist Pharmaceuticals Inc.
Overall, the sector has announced $244.3 billion in mergers and acquisitions this year and has raised $78.3 billion in debt and $12.9 billion in equity to fund those deals, according to Dealogic. Both are record amounts for the sector through the first 4 1/2 months of the year.
Acquirers have announced $1.47 trillion in deals world-wide in 2015, a 30% increase from the same period last year and the highest total since 2007.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Merck Chart |
1 Month Merck Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions